182 related articles for article (PubMed ID: 16005636)
41. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases.
Finiels F; Gimenez y Ribotta M; Barkats M; Samolyk ML; Robert JJ; Privat A; Revah F; Mallet J
Neuroreport; 1995 Dec; 7(1):373-8. PubMed ID: 8742491
[TBL] [Abstract][Full Text] [Related]
42. Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF.
Pezet S; Krzyzanowska A; Wong LF; Grist J; Mazarakis ND; Georgievska B; McMahon SB
Mol Ther; 2006 Jun; 13(6):1101-9. PubMed ID: 16504588
[TBL] [Abstract][Full Text] [Related]
43. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
[TBL] [Abstract][Full Text] [Related]
44. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.
O'Rourke JP; Newbound GC; Kohn DB; Olsen JC; Bunnell BA
J Virol; 2002 Feb; 76(3):1510-5. PubMed ID: 11773424
[TBL] [Abstract][Full Text] [Related]
45. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
[TBL] [Abstract][Full Text] [Related]
46. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
47. Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats.
Mitani Y; Maruyama J; Jiang BH; Sawada H; Shimpo H; Imanaka-Yoshida K; Kaneda Y; Komada Y; Maruyama K
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):142-9. PubMed ID: 18603067
[TBL] [Abstract][Full Text] [Related]
48. Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro.
Vincent AM; Feldman EL; Song DK; Jung V; Schild A; Zhang W; Imperiale MJ; Boulis NM
Neuromolecular Med; 2004; 6(2-3):79-85. PubMed ID: 15970625
[TBL] [Abstract][Full Text] [Related]
49. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
[TBL] [Abstract][Full Text] [Related]
50. Stable gene expression with VSV-G pseudotyped-retrovirus vector in the rat liver.
Shiraishi M; Tomori H; Nagahama M; Taira K; Nozato E; Sugawa H; Ishida A; Muto Y
J Surg Res; 1999 Jun; 84(2):168-73. PubMed ID: 10357915
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
52. Members of several gene families influence survival of rat motoneurons in vitro and in vivo.
Hughes RA; Sendtner M; Thoenen H
J Neurosci Res; 1993 Dec; 36(6):663-71. PubMed ID: 8145295
[TBL] [Abstract][Full Text] [Related]
53. Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector.
Whitelaw CB; Radcliffe PA; Ritchie WA; Carlisle A; Ellard FM; Pena RN; Rowe J; Clark AJ; King TJ; Mitrophanous KA
FEBS Lett; 2004 Jul; 571(1-3):233-6. PubMed ID: 15280048
[TBL] [Abstract][Full Text] [Related]
54. Differential effects of virulent and avirulent equine infectious anemia virus on macrophage cytokine expression.
Lim WS; Payne SL; Edwards JF; Kim I; Ball JM
Virology; 2005 Feb; 332(1):295-306. PubMed ID: 15661161
[TBL] [Abstract][Full Text] [Related]
55. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
56. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.
Capowski EE; Schneider BL; Ebert AD; Seehus CR; Szulc J; Zufferey R; Aebischer P; Svendsen CN
J Neurosci Methods; 2007 Jul; 163(2):338-49. PubMed ID: 17397931
[TBL] [Abstract][Full Text] [Related]
57. Differential effects on kidney and liver growth of a non-viral hGH-expression vector in hypophysectomized mice.
Khamaisi M; Søndergaard M; Segev Y; Dagnaes-Hansen F; Jensen TG; Landau D; Raz I; Flyvbjerg A
Growth Horm IGF Res; 2007 Aug; 17(4):279-87. PubMed ID: 17392003
[TBL] [Abstract][Full Text] [Related]
58. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
[TBL] [Abstract][Full Text] [Related]
59. Adenoviral gene transfer of hepatocyte growth factor prevents death of injured adult motoneurons after peripheral nerve avulsion.
Hayashi Y; Kawazoe Y; Sakamoto T; Ojima M; Wang W; Takazawa T; Miyazawa D; Ohya W; Funakoshi H; Nakamura T; Watabe K
Brain Res; 2006 Sep; 1111(1):187-95. PubMed ID: 16884699
[TBL] [Abstract][Full Text] [Related]
60. Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis.
Keir SD; Xiao X; Li J; Kennedy PG
J Neurovirol; 2001 Oct; 7(5):437-46. PubMed ID: 11582516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
